Abstract:Introduction: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease with high prevalence and mortality. In some acute exacerbations of COPD (AECOPD) in patients with no obvious signs of infection, early antibiotic treatment seems to clinically improve the disease, but more studies are needed to determine the prognostic impact of antibiotic treatment in AECOPD patients with no obvious signs of infection. Purpose: To clarify the impact of antibiotic treatment on the short-term and long-term prognoses of AECOPD patients without obvious signs of infection. Methods: The impact of the two treatment methods on the prognosis of patients was compared at 30, 90, 180, and 360 days after discharge. A multicenter, randomized, parallel-controlled clinical trial was conducted in a department of respiratory and critical care medicine in Central China. All patients met the inclusion criteria for AECOPD, and the patients were randomly assigned to the antibiotic group or the nonantibiotic group at a 1:1 ratio. Patients in the antibiotic group were given moxifloxacin 400 mg/day intravenously for 7 days. Patients in the nonantibiotic group were intravenously injected with the same amount of normal saline as the amount of moxifloxacin given to those in the antibiotic group for 7 days. Results: There were 406 patients in the antibiotic group and 410 patients in the nonantibiotic group. During the short-term and long-term follow-ups, the acute exacerbation frequency, intensive care unit (ICU) treatment rate, mortality, and mMRC and CAT scores were not significantly different between the two groups ( p > 0.05). At the 180- and 360-day follow-ups, the forced expiratory volume in 1 s (FEV1%) and peak expiratory flow (PEF) were not significantly different between the two groups ( p > 0.05). The 30-day readmission rate was significantly lower in the antibiotic group than in the nonantibiotic group ( p < 0.05). The time from discharge to the first acute exacerbation was not significantly different between the two groups ( p > 0.05). The length of the first hospital stay after discharge was significantly lower in the antibiotic group (5.84 days) than in the nonantibiotic group (6.75 days) ( p < 0.05). At the 30-day follow-up, the acute exacerbation frequency, age, C-reactive protein (CRP) level, and sputum viscosity were significantly greater in the nonantibiotic group than in the antibiotic group ( p 62.5 years, with a CRP level >12.56 mg/L or with a sputum viscosity >III, in the nonantibiotic group than in those in the antibiotic group, suggesting that the short-term prognosis was poor. Conclusion: Patients who are >62.5 years of age, have a CRP concentration >12.56 mg/L, or have a sputum viscosity >III without obvious signs of infection should be treated with antibiotics to improve their short-term prognosis. Clinical Trial Registration:: (https://www.chictr.org.cn), (ChiCTR1800018921)

Chronic Obstructive Pulmonary Disease with Acute Aggravating Period of Etiology and Drug Resistance Analysis

Distribution and Antibiotic Resistance of Pathogens from Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Analysis of bacterial pathogens isolated from lower respiratory tract in patients with acute exacerbation of chronic obstructive pulmonary diseases

Detection of relationship between pathogens of acute exacerbation of chronic obstructive pulmonary disease and comprehensive evaluation classification

Bacteriology in Acute Exacerbation in Patients Hospitalized Frequently for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Spectrum and Antimicrobial Resistance of Common Pathogenic Bacteria Isolated from Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Mainland of China.

Dection and Analysis of Pathogens in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Distribution and drug resistance of pathogens from lower respiratory tract of patients with acute exacerbated chronic obstructive pulmonary diseases in respiratory intensive care unit

Distribution and Antibiotic Resistance of Isolates from Lower Respiratory Tract in Mechanically Ventilated Patients with COPD

Pathogens in Patients with Chronic Obstructive Pulmonary Disease at Acute Exacerbation

Characteristics of Pathogens Causing Ventilator-Associated Pneumonia in Patients with Chronic Obstructive Pulmonary Diseases During Acute Exacerbation Period

Bacterial etiology in early re-admission patients with acute exacerbation of chronic obstructive pulmonary disease

Pathogen and Drug-Resistance Analysis of Lower-Respiratory-tract Bacterial Infection in Chronic Obstructive Pulmonary Disease

Gram-negative bacteria for pulmonary infections in chronic obstructive pulmonary disease and drug resistance analysis

Investigation of Pathogenic Microorganisms and Drug Resistance of Chronic Respiratory Disease Combined with Low Respiratory Tract Infection

Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease

Pathogenic Bacteria Distribution and Drug Resistance Analysis in HIV/AIDS Patients with Lower Respiratory Tract Infection in Yunnan Province

The use of antibiotics in the early stage of acute exacerbation of chronic obstructive pulmonary disease in patients without obvious signs of infection: a multicenter, randomized, parallel-controlled study

A Survey of Antibiotic Usage Characteristics in Treatment of Acute Exacerbation of COPD Patients in National Hospital 74

Investigation of the Relationship Between Bacteria Pathogens in Sputum and Lung Function with Acute Exacerbations of COPD

Association of Sputum Microbiome with Clinical Outcome of Initial Antibiotic Treatment in Hospitalized Patients with Acute Exacerbations of COPD.